Examining visual fields is an integral part of a full ophthalmic evaluation. Several methods for assessing visual field loss are available, and the choice of which to use depends on the patient's age, health, visual acuity, ability to concentrate, and socio-economic status. Available techniques can test the full field (including confrontation, tangent screen, Goldmann perimetry and automated perimetry), or assess just the central field of vision, such as the Amsler Grid ( Figure 1) .
If undertaking or interpreting visual field tests, it is a good idea to undergo the tests yourself. You will probably find that undergoing a visual field test can be difficult, requiring an understanding of what is required, an ability to perform tasks quickly, and high levels of concentration. Some methods require patients to press a buzzer when they see a target, and this requires quick reflexes and nimble hands. Undergoing the experience yourself will enable you to see how it is possible for patients to be slow and to make mistakes; this will help you to be patient and realise that you may need to explain the test several times. It will also give you greater insight when interpreting the test results, and can be very useful for teaching others how to explain the process to patients.
This article focuses on some of the more practical aspects of visual field testing, with an emphasis on assessing glaucoma.
Key facts about visual field testing
1 Manual and/or automated visual field testing is subjective: it is totally dependent on the co-operation and responses of the patient. Poor results that are difficult to interpret are often due to the fact that the patient either did not understand what was required, or did understand but was unable to respond. 2 Abnormalities in the visual field are a sign of damage anywhere in the visual system from the retina through to the brain's visual cortex. Visual field loss can be diffuse (as with cataract or corneal opacification), but more commonly there are isolated defects. The visual field defects associated with glaucoma appear to be fairly non-specific, although typical loss fits with the arrangement of the retinal ganglion cell axons within the retinal nerve fibre layer of the retina.
Relatively specific glaucomatous visual field defects (see Figure 3 for examples) include:
1 a nasal step defect obeying the horizontal meridian 2 a temporal wedge defect 3 the classic arcuate defect, which is a comma-shaped extension of the blind spot 4 a paracentral defect 10-20º from the blind spot 5 an arcuate defect with peripheral breakthrough 6 generalised constriction (tunnel vision) 7 temporal-sparing severe visual field loss 8 total loss of field.
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(field defects), and tends to be more reliable and consistent, particularly for detecting glaucomatous visual field loss. 8 In order to detect glaucomatous field loss, it is important to test for differences in the superior and inferior hemi-fields (above or below the horizontal raphé) and hunt for defects such as a nasal step, which is typical of glaucoma. 9 In order to detect neurological field loss, test for differences either side of the vertical meridian.
New technologies and the future
Other technologies are available and being developed in the hope that formal visual field testing will become easier, more reliable, more affordable, and more widespread -using equipment that can detect glaucoma earlier than standard perimetry. These emerging technologies include:
• short-wavelength (blue-yellow) automated perimetry (SWAP) • frequency doubling technology (FDT) perimetry • motion displacement perimetry (MDP).
Over the next few years, it is highly likely that there will be a wider range of affordable visual field testing equipment available. This is good news since it means that glaucoma detection as well as management can be greatly improved. Training in visual field testing should be an integral part of ophthalmology residency programmes, as well as of training programmes for mid-level eye-care workers, so that awareness and expertise in glaucoma care become an integral part of the work of eye care workers everywhere.
Careful detection of visual field defects can be diagnostic of many ophthalmic and/or neurological conditions, including glaucoma. In glaucoma -as well as other conditions -it is vital to repeat visual field testing to track any changes over time.
Ideally, the same method of testing should be used for baseline and subsequent follow-up. In glaucoma, if visual field loss is progressive, it may mean that control of intraocular pressure (IOP) is inadequate. Be aware, though, that patients may remember to use their eye drops just before they come to the clinic, so that their IOP may appear to be controlled. It is far better to monitor control by assessment of the optic disc and visual fields than to rely on IOP alone. The first thing you should do is to ask if the patient has noticed a visual field defect. The problem with this approach alone is that early (or even moderate) visual field defects often go unnoticed, particularly if only one eye is affected. Useful questions to ask are:
Part 2 Features of glaucomatous visual field defects
• Have you noticed if any part of your vision is missing in either eye? In addition, it is essential to enquire about past ophthalmic and medical history, concentrating on family history, dietary/ drug/smoking/alcohol history, and whether there are any additional ophthalmic or neurological symptoms. Visual field testing using confrontation only takes a few minutes, and should be mastered by all eye care workers, since it can provide a lot of useful information. Initially it is best to try and detect gross (absolute) defects. Position yourself in front of the patient, facing her/him with your face level with that of her/his, at a distance of about a metre. A comparison of examiner and patient fields is made, the assumption being that you, as the examiner, have normal visual fields (this is another reason why you should undergo visual field testing yourself).
First test the binocular visual field and then test each eye separately. A defect is detected by the absence of a patient response to the showing of a target, when the target is visible to you. The differential diagnosis for visual field loss similar to that seen with glaucoma includes:
• optic nerve head drusen • retrobulbar optic neuritis
• tilted optic nerve • anterior ischaemic optic neuropathy • neurological field defects (especially bitemporal homonymous hemianopia) • other rare optic nerve disorders
Some non-glaucomatous visual field defects are shown in Figure 4 . This article does not cover all the details relating to the use of automated devices and users fortunate to have access to such devices should read and carefully adhere to the manufacturer's instruction manuals. Learning how to fully interpret standard automated perimetry (SAP) visual field printouts is also beyond the scope of this article and the reader is advised to source this information from an appropriate textbook. Readers with internet access can visit the Community Eye Health Journal website (www.cehjournal.org) for an additional online-only article about glaucoma and visual fields.
amsler chart testing
A printed grid (Amsler chart) can be used to detect subtle central defects (uncommon in patients with glaucoma) as well as paracentral defects (fairly common in patients with glaucomaespecially those with normal tension glaucoma). Test one eye at a time, correcting for any near refractive errors. Patients should hold the chart at a comfortable reading distance from their uncovered eye, and stare at the central spot of the grid. Ask them to identify and then point out any areas where the grid is missing or distorted. Missing areas may suggest paracentral glaucomatous visual field loss, whereas distortion is more common with macular disorders (Figure 6 ). Testing each eye to confrontation 1 Ask the patient to cover their own eye with the palm of their hand (not their fingers, as it is easy to peep between fingers). Remember that you should close your eyes in turn too, so that you are comparing the field in your right eye with the field of the patient's left eye, for example ( Figure 5 ). 2 Do the finger counting test first (static testing). Be sure to test on both the left and the right for each eye tested. 3 Next, bring your target finger from the far periphery in towards the central region (kinetic testing). Ask the patient to say when they first see the target.
Repeat from several different directions, ensuring that the full 360° for each eye is tested. The examiner should remember to perform kinetic testing at a speed appropriate for the patient's responses. 4 Next, test the peripheral field with a white-headed neurological pin (beyond a central 30° radius) and the central field with a red-headed neurological pin (within a 30° radius).
Testing with neurological pin targets gives much more accurate results than testing with fingers, and can detect earlier visual field loss. Red-headed neurological pins are also useful for assessing the size of the blind spot (e.g., with papilloedema), again by comparing the size of your blind spot with that of the patient's. In addition, red-headed neurological pins can be used to test for red-desaturation in early optic nerve disease.
Part 4 Other visual field tests
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Tangent screen testing (campimetry)
Tangent screen testing uses a flat testing surface and is useful for testing the central visual field, but for testing beyond 30° its value is limited (Figure 7 ). The tangent screen is usually a black felt screen mounted on a wall and testing is performed while the patient is sitting down. The screen should be well illuminated and appropriate for the specific type of test and target used. Most screens have circular white stitching or markings every 5° from a central fixation spot, up to 30°. The screen also has radial markings around the fixation point that start at the 180° meridian and are usually spaced 22.5° apart.
A disadvantage of campimetry is that no permanent record is generated, however, it can provide a convenient and quick way to obtain an impression of a fi eld defect in a more formal manner than is achieved by confrontation testing.
goldmann perimetry
The Goldmann visual field analyser or perimeter (Figure 8 ) is a device that enables kinetic visual field testing, is more standardised than tangent screen testing campimetry), and generates a permanent record of the visual field, making it more sensitive, reproducible, and better for detecting change over time. Many of the practical principles of Goldmann perimetry are similar to those relating to campimetry (and are not, therefore, repeated in this section).
The Goldmann perimeter consists of an illuminated hemispheric bowl upon which target spots of light are shone and moved from non-seeing regions to seeing regions. For kinetic testing, the examiner is able to move the target where they choose throughout a test, observe that the patient's eye is fi xating on the fi xation spot, communicate with the patient and document boundaries (isopters) between seeing and non-seeing regions to produce an exact drawing of visual fi elds. 
Standard automated perimetry
Automated visual field analysers have been developed, but these are expensive
and not yet available in all departments throughout the world. However, research has shown that glaucomatous visual field loss is best detected and is managed with high reliability when automated perimetry is performed. SAP machines are highly technical and use intelligent computer software. It is hoped, therefore, that SAP will be used more widely with time. SAP testing may be performed as a threshold or suprathreshold analysis. With suprathreshold analysis, the intensity of the stimulus target is not reduced to the level of detection/non-detection. A threshold analysis is more sensitive, but takes longer and is more susceptible to detecting artefacts (changes in the data that are due to the testing process itself, and not as a result of actual problems with the visual fi eld).
SAP analysis provides the following:
• reliability indices (test duration, fixation losses, false-positive and false-negative error scores) • a pictorial grey-scale plot of the visual field
• a plot of raw data sensitivities for each test spot • global indices (in dB) indicating how the height and shape of the patient's hill of vision deviates from normal. Mean deviation gives the average difference between the patient's overall visual field sensitivity compared to a normal, age-corrected, reference field. Pattern standard deviation gives the standard deviation of the tested spot deviations from normal, thereby providing a measure of the degree to which the shape of a patient's field differs from normal • a total deviation plot, together with a probability map indicating the likelihood for each missed point that it is abnormal • a pattern standard deviation plot, together with its probability map • analyses of change in visual field sensitivity with time • results of the glaucoma hemi-field test -a relatively crude test for detecting glaucoma, based on the assumption that glaucoma frequently affects the superior hemi-field more than the inferior hemi-field or vice versa.
The key feature of a glaucomatous visual field defect is an abnormality on the pattern standard deviation plot, which also shows on the total deviation plot. A fi eld defect on the total deviation plot, in the absence of a defect on the pattern standard deviation plot, can be due to glaucoma (diffuse fi eld loss), but is more likely to be due to media opacity (e.g. cataract).
A fi eld defect that appears more extensive on the total deviation plot than on the pattern standard deviation plot may indicate co-morbidity (e.g. cataract and glaucoma). 
